Why Stryker Orthobiologics
OP-1 (BMP-7) has demonstrated the ability to stimulate, repair, and regenerate bone
OP-1 (BMP-7) has demonstrated the ability to stimulate, repair, and regenerate bone
Stryker has invested over 20 years of clinical research in developing a wide range of biological technologies that hold the promise of regeneration and healing for patients suffering from bone, cartilage and soft tissue injuries and defects. Stryker offers biomaterials and regenerative biological products for clinical specialties including trauma, spine, craniomaxillofacial and joint replacement. Our advanced biological solutions have the potential to produce better results for countless patients.